104 related articles for article (PubMed ID: 6807261)
1. Probucol-lipid pharmacology.
Kritchevsky D
Artery; 1982; 10(1):1-6. PubMed ID: 6807261
[No Abstract] [Full Text] [Related]
2. Pharmacology and toxicology of probucol.
Marshall FN
Artery; 1982; 10(1):7-21. PubMed ID: 7046693
[No Abstract] [Full Text] [Related]
3. [Pharmacology of probucol. I].
Donatelli L
Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
[No Abstract] [Full Text] [Related]
4. An overview of the biochemical pharmacology of probucol.
Barnhart JW; Rytter DJ; Molello JA
Lipids; 1977 Jan; 12(1):29-33. PubMed ID: 189154
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacology of probucol. II].
Donatelli L
Clin Ter; 1984 Mar; 108(6):475-95. PubMed ID: 6233067
[No Abstract] [Full Text] [Related]
6. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
[TBL] [Abstract][Full Text] [Related]
7. Effect of probucol on bile composition in man.
Jirsa M; Marecek Z; Kerdac V; Kucerova L
Artery; 1982; 10(1):44-7. PubMed ID: 7092575
[No Abstract] [Full Text] [Related]
8. [Experimental pharmacology of probucol (author's transl)].
Choisy H; Millart H
Nouv Presse Med; 1980 Oct; 9(40):2981-4. PubMed ID: 7443435
[TBL] [Abstract][Full Text] [Related]
9. [Probucol: mechanism of action (author's transl)].
Infante R
Nouv Presse Med; 1980 Oct; 9(40):2976-80. PubMed ID: 7443434
[TBL] [Abstract][Full Text] [Related]
10. [The effects of probucol in man (author's transl)].
Leutenegger M
Nouv Presse Med; 1980 Oct; 9(40):2985-9. PubMed ID: 7443436
[TBL] [Abstract][Full Text] [Related]
11. The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterol.
Duncan CH; Best MM
Atherosclerosis; 1973; 17(2):161-6. PubMed ID: 4709117
[No Abstract] [Full Text] [Related]
12. Metabolic studies with probucol in hypercholesterolaemia.
Simons LA; Balasubramaniam S; Beins DM
Atherosclerosis; 1981; 40(3-4):299-308. PubMed ID: 7332609
[TBL] [Abstract][Full Text] [Related]
13. Newer hypolipidemic agents.
Kritchevsky D
Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
[No Abstract] [Full Text] [Related]
14. AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agent.
Sundell CL; Somers PK; Meng CQ; Hoong LK; Suen KL; Hill RR; Landers LK; Chapman A; Butteiger D; Jones M; Edwards D; Daugherty A; Wasserman MA; Alexander RW; Medford RM; Saxena U
J Pharmacol Exp Ther; 2003 Jun; 305(3):1116-23. PubMed ID: 12626663
[TBL] [Abstract][Full Text] [Related]
15. A little more information about aggravation of probucol-induced HDL-reduction by clofibrate.
Yokoyama S; Yamamoto A; Kurasawa T
Atherosclerosis; 1988 Mar; 70(1-2):179-81. PubMed ID: 3355613
[No Abstract] [Full Text] [Related]
16. Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
Iliskovic N; Singal PK
Am J Pathol; 1997 Feb; 150(2):727-34. PubMed ID: 9033285
[TBL] [Abstract][Full Text] [Related]
17. [Clofibrate and phosphate metabolism].
Michailov ML
Cor Vasa; 1984; 26(4):309-16. PubMed ID: 6488804
[TBL] [Abstract][Full Text] [Related]
18. Probucol: pharmacology and clinical application.
Zimetbaum P; Eder H; Frishman W
J Clin Pharmacol; 1990 Jan; 30(1):3-9. PubMed ID: 2406299
[TBL] [Abstract][Full Text] [Related]
19. [New derivatives of clofibrate and probucol. Preliminary study of their hypolipemic activity].
de Meglio P; Ravenna F; Manzardo S; Gentili P; Riva M
Farmaco Sci; 1985 Nov; 40(11):833-44. PubMed ID: 4085644
[TBL] [Abstract][Full Text] [Related]
20. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
Artery; 1982; 10(2):88-94. PubMed ID: 7092581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
